Thailand wants to ban cannabis again. The new conservative government wants to go back to prohibition.
Thailand was the first Asian country to decriminalize the recreational use of cannabis. Now the new government could bring about a turnaround in Thai drug policy. That is reported by Focus. There is a conservative government in power that adheres to the dogma of prohibition. After just 18 months there could now be prison sentences for cannabis users again.
Find out why Thailand wants to ban cannabis again and read the most important cannabis news from around the world, with the Hemp.im mobile app.
Only the medical use of cannabis should remain permitted in Thailand
A lot of penalties are planned for violations. From heavy fines to prison stays. A completely excessive punishment for people who want to freely develop their personality with cannabis. “Thai Prime Minister Srettha Thavisin said in September that his government wanted to “correct” the cannabis laws, according to FOCUS. For the first time, advertising and marketing for THC products are to be banned.
It was never the intention that Thais and tourists should be allowed to smoke weed in public. Former Health Minister Anutin Charnvirakul says: “We have always emphasized that cannabis and its raw materials should only be used for medical and health purposes,” he says.
In Thailand, many people have benefited from the cannabis boom. Now it could mean the end for the cannabis industry. An entrepreneur from Bangkok describes the government’s plan as a “short-circuit reaction”. There is no rational basis to be found in such a decision. This would mean that Thailand would be taking a fatal step backwards after such a short period of time.
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in Hanf Journal. A third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
The TopRanked.io Weekly Digest: What’s Hot in Affiliate Marketing [1xBet Affiliate Program]
Wanna discover one weird sports betting niche with plenty of low-hanging fruit just waiting for you to exploit? Then read...
Which Are the Most Important Fintech News from February 2024
Monite secured $6 million in a top-up financing round, bringing its total seed-stage funding to $16 million. The funds will...
Spanish Pharma Listed Companies Reduce Their Profits by 37% in 2023
Of the Spanish pharma listed companies, PharmaMar has suffered the most significant drop in profits due to generic drug competition...
How Much Does Europe Invest in Sustainability
Europe is moving rapidly towards a renewal of the regulatory framework for sustainability , with the obligation for almost 50,000...
The German Medical Cannabis Market Could Be Worth Three Billion
Currently, the German medical cannabis market serves a relatively small part of the population, with approximately 28,000 patients, or less...
Fintech1 week ago
Redeban Boosts its Leadership in Colombia with the Acquisition of SoyYo
Biotech2 weeks ago
Haier Receives Authorization from the Cnmc to Buy 20% of Shanghai Raas from Grifols
Impact Investing4 days ago
Guarantee Fund in Italy Brings Maximum Business Coverage to 5 Million
Biotech1 week ago
Gotham Insists on Projecting Its Doubts on Grifols